On November 4, 2022 Fate Therapeutics, Inc. (the "Company" or "Fate Therapeutics") (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, reported that the Company will present at the following upcoming investor conferences (Press release, Fate Therapeutics, NOV 4, 2022, View Source [SID1234623161]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen’s 6th Annual IO Next Summit available on demand on Friday, November 11, 2022 at 2:10 PM ET
Jefferies London Healthcare Conference on Wednesday, November 16, 2022 at 12:55 PM GMT, 7:55 AM ET, in London, United Kingdom
Piper Sandler 34th Annual Healthcare Conference on Tuesday, November 29, 2022 at 12:00 PM ET in New York, New York
A live webcast, if recorded, of each presentation can be accessed under "Events & Presentations" in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast will be available on the Company’s website shortly after the event.